PBIGF vs JNJ: Which Stock is Better?

Side-by-side comparison of Paradigm Biopharmaceuticals Limited and Johnson & Johnson in 2026

Comparison Updated:

PBIGF

Paradigm Biopharmaceuticals Limited

$0.18

JNJ

Johnson & Johnson

$234.18

Key Metrics Comparison

MetricPBIGFJNJWinner
Market Cap$81.32M$565.22BJNJ
P/E RatioN/A21.26JNJ
EPS (TTM)$N/A$11.03JNJ
Revenue Growth0.5%0.1%PBIGF
Gross Margin24.5%68.0%JNJ

Analyze PBIGF

Full quant analysis

Analyze JNJ

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is PBIGF or JNJ a better investment?

Comparing PBIGF and JNJ: Paradigm Biopharmaceuticals Limited has a market cap of $81.32M while Johnson & Johnson has $565.22B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between PBIGF and JNJ?

PBIGF (Paradigm Biopharmaceuticals Limited) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: PBIGF or JNJ?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: PBIGF or JNJ?

PBIGF has higher revenue growth at 0.5% vs 0.1% for JNJ.

Which company is more profitable: PBIGF or JNJ?

Johnson & Johnson (JNJ) has higher gross margins at 68.0% compared to 24.5% for PBIGF.

Which is the larger company: PBIGF or JNJ?

Johnson & Johnson (JNJ) is larger with a market cap of $565.22B compared to $81.32M for PBIGF.

Should I buy PBIGF or JNJ in 2026?

Both PBIGF and JNJ have investment merit. PBIGF trades at $0.18 while JNJ trades at $234.18. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between PBIGF and JNJ stock?

Key differences: Market Cap ($81.32M vs $565.22B), P/E Ratio (N/A vs 21.3x), Revenue Growth (0.5% vs 0.1%), Gross Margin (24.5% vs 68.0%).

Popular Stock Comparisons